Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System.

Nayerhoda R, Hill A, Beitelshees M, Jones C, Pfeifer B.

Materials (Basel). 2019 Sep 1;12(17). pii: E2809. doi: 10.3390/ma12172809.

2.

Antigen delivery format variation and formulation stability through use of a hybrid vector.

Beitelshees M, Hill A, Li Y, Chen M, Ahmadi MK, Smith RJ Jr, Andreadis ST, Rostami P, Jones CH, Pfeifer BA.

Vaccine X. 2019 Jan 30;1:100012. doi: 10.1016/j.jvacx.2019.100012. eCollection 2019 Apr 11.

3.

Engineering a Next-Generation Glycoconjugate-Like Streptococcus pneumoniae Vaccine.

Hill AB, Beitelshees M, Nayerhoda R, Pfeifer BA, Jones CH.

ACS Infect Dis. 2018 Nov 9;4(11):1553-1563. doi: 10.1021/acsinfecdis.8b00100. Epub 2018 Sep 14.

PMID:
30180541
4.

Standardization of Pneumococcal Biofilm Release to PncO Expression, a Predictive Measurement of Virulence.

Hill A, Beitelshees M, Pfeifer BA, Jones CH.

Infect Immun. 2018 Aug 22;86(9). pii: e00494-18. doi: 10.1128/IAI.00494-18. Print 2018 Sep.

5.

Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design.

Beitelshees M, Hill A, Jones CH, Pfeifer BA.

Materials (Basel). 2018 Jun 26;11(7). pii: E1086. doi: 10.3390/ma11071086. Review.

6.

Pressing diseases that represent promising targets for gene therapy.

Beitelshees M, Hill A, Rostami P, Jones CH, Pfeifer BA.

Discov Med. 2017 Dec;24(134):313-322. Review.

7.

Comprehensive vaccine design for commensal disease progression.

Jones CH, Zhang G, Nayerhoda R, Beitelshees M, Hill A, Rostami P, Li Y, Davidson BA, Knight P 3rd, Pfeifer BA.

Sci Adv. 2017 Oct 18;3(10):e1701797. doi: 10.1126/sciadv.1701797. eCollection 2017 Oct.

8.

Bimodal Targeting Using Sulfonated, Mannosylated PEI for Combined Gene Delivery and Photodynamic Therapy.

Chitgupi U, Li Y, Chen M, Shao S, Beitelshees M, Tan MJ, Neelamegham S, Pfeifer BA, Jones C, Lovell JF.

Photochem Photobiol. 2017 Mar;93(2):600-608. doi: 10.1111/php.12688. Epub 2017 Feb 7.

9.

In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector.

Li Y, Beitelshees M, Fang L, Hill A, Ahmadi MK, Chen M, Davidson BA, Knight P 3rd, Smith RJ Jr, Andreadis ST, Hakansson AP, Jones CH, Pfeifer BA.

Sci Adv. 2016 Jul 1;2(7):e1600264. doi: 10.1126/sciadv.1600264. eCollection 2016 Jul.

10.

Directed vaccination against pneumococcal disease.

Li Y, Hill A, Beitelshees M, Shao S, Lovell JF, Davidson BA, Knight PR 3rd, Hakansson AP, Pfeifer BA, Jones CH.

Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):6898-903. doi: 10.1073/pnas.1603007113. Epub 2016 Jun 6.

11.

Enhancing vaccine effectiveness with delivery technology.

Beitelshees M, Li Y, Pfeifer BA.

Curr Opin Biotechnol. 2016 Dec;42:24-29. doi: 10.1016/j.copbio.2016.02.022. Epub 2016 Mar 6. Review.

Supplemental Content

Loading ...
Support Center